Ms. LilyWhat can I do for you?
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
PRODUCT CATEGORIES
Product categories of Acalabrutinib, we are specialized manufacturers from China, Calquence, Acalabrutinib Cll suppliers/factory, wholesale high-quality products of Calquence Cll R & D and manufacturing, we have the perfect after-sales service and technical support. Look forward to your cooperation!
View:
CAS NO.1420477-60-6 Acalabrutinib 99.0%+
Packaging: Double PE Bag with Foil Bag or as required
Supply Ability: As per order
Min. Order: 0.01 Kilogram
Certificate: ISO9001
Model No.: DM 1420477-60-6
Golden Product Acalabrutinib CAS NO 1420477 60 6 with Best Price Product Name Acalabrutinib CAS NO 1420477 60
Acalabrutinib Intermediate/4-(pyridin-2-yl-aminocarbonyl)benzeneboronic acid CAS 850568-25-1
Brand: DM
Packaging: double PE with aluminium foil bag
Min. Order: 1 Gram
Certificate: ISO9001
Model No.: CAS 850568-25-1
Acalabrutinib Intermediate 4 pyridin 2 yl aminocarbonyl benzeneboronic acid CAS 850568 25 1 CAS 850568 25 1 MF C12H11BN2O3 MW 242 04 Synonyms 4 PYRIDIN 2 YL AMINOCARBONYL BENZENEBORONIC ACID 4 PYRIDIN 2 YL AMINOCARBONYLPHENYLBORONIC ACID N 2 PYRIDINYL 4 BORONOBENZAMIDE 4 Pyridin 2 yl aminocarbonyl benzeneboronic acid...
Acalabrutinib CAS:1420477-60-6
Brand: DM
Packaging: double PE with aluminium foil bag
Min. Order: 1 Gram
Certificate: ISO9001
Model No.: CAS:1420477-60-6
Name Acalabrutinib ACP196 CAS 1420477 60 6 Appearance White crystalline powder Application API Acalabrutinib also known as ACP 196 is an orally available inhibitor of Bruton s tyrosine kinase BTK with potential antineoplastic activity Upon administration ACP 196 inhibits the activity of BTK and prevents the activation...
China Acalabrutinib Suppliers
Acalabrutinib, also known as ACP-196, is an orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, ACP-196 inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed in B-cell malignancies; it plays an important role in B lymphocyte development, activation, signaling, proliferation and survival.
Hot Products
Send Inquiry
Ms. Lily
Tel:86-311-67260775
Fax:86-311-67591193
Mobile Phone:+8615933619867
Email:sales@dingminpharma.com
Address:No.52 Zhaiying South Street,Yuhua District, Shijiazhuang, Hebei
Related Products List
Mobile Site
